Instil Bio Analyst Ratings
Instil Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 473.07% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 08/17/2023 | 473.07% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 06/29/2023 | 473.07% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 04/05/2023 | 1619.2% | Truist Securities | → $6 | Reinstates | → Hold |
| 12/12/2022 | 473.07% | Morgan Stanley | $6 → $2 | Maintains | Equal-Weight |
| 11/17/2022 | 3911.46% | Baird | $24 → $14 | Maintains | Outperform |
| 11/01/2022 | 1619.2% | Morgan Stanley | $8 → $6 | Maintains | Equal-Weight |
| 11/01/2022 | 6776.79% | Baird | $31 → $24 | Maintains | Outperform |
| 11/01/2022 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 09/06/2022 | 8782.52% | Baird | $34 → $31 | Maintains | Outperform |
| 08/24/2022 | 2192.26% | Morgan Stanley | $9 → $8 | Maintains | Equal-Weight |
| 08/23/2022 | 4484.53% | Truist Securities | $25 → $16 | Maintains | Buy |
| 06/06/2022 | 2478.8% | Morgan Stanley | $14 → $9 | Maintains | Equal-Weight |
| 05/24/2022 | 3911.46% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 08/13/2021 | 9642.12% | Baird | → $34 | Initiates Coverage On | → Outperform |
| 05/26/2021 | 6490.26% | Morgan Stanley | $24 → $23 | Maintains | Equal-Weight |
| 04/13/2021 | 8782.52% | Jefferies | → $31 | Initiates Coverage On | → Buy |
| 04/13/2021 | 6776.79% | Morgan Stanley | → $24 | Initiates Coverage On | → Equal-Weight |
| 04/13/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 04/13/2021 | 9069.05% | Truist Securities | → $32 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/14/2023 | 473.07% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
| 08/17/2023 | 473.07% | HC Wainwright & Co. | → 2 美元 | 重申 | 購買 → 購買 |
| 06/29/2023 | 473.07% | HC Wainwright & Co. | → 2 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/05/2023 | 1619.2% | Truist 證券 | → 6 美元 | 恢復 | → 按住 |
| 12/12/2022 | 473.07% | 摩根士丹利 | 6 美元 → 2 美元 | 維護 | 等重 |
| 11/17/2022 | 3911.46% | 貝爾德 | 24 美元 → 14 美元 | 維護 | 跑贏大盤 |
| 11/01/2022 | 1619.2% | 摩根士丹利 | 8 美元 → 6 美元 | 維護 | 等重 |
| 11/01/2022 | 6776.79% | 貝爾德 | 31 美元 → 24 美元 | 維護 | 跑贏大盤 |
| 11/01/2022 | — | Cowen & Co. | 降級 | 跑贏大盤 → 市場表現 | |
| 09/06/2022 | 8782.52% | 貝爾德 | 34 美元 → 31 美元 | 維護 | 跑贏大盤 |
| 2022 年 8 月 24 日 | 2192.26% | 摩根士丹利 | 9 美元 → 8 美元 | 維護 | 等重 |
| 2022 年 8 月 23 日 | 4484.53% | Truist 證券 | 25 美元 → 16 美元 | 維護 | 購買 |
| 2022 年 6 月 6 日 | 2478.8% | 摩根士丹利 | 14 美元 → 9 美元 | 維護 | 等重 |
| 2022 年 5 月 24 日 | 3911.46% | 摩根士丹利 | 15 美元 → 14 美元 | 維護 | 等重 |
| 08/13/2021 | 9642.12% | 貝爾德 | → 34 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 2021 年 5 月 26 日 | 6490.26% | 摩根士丹利 | 24 美元 → 23 美元 | 維護 | 等重 |
| 04/13/2021 | 8782.52% | 傑富瑞集團 | → 31 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/13/2021 | 6776.79% | 摩根士丹利 | → 24 美元 | 啓動覆蓋範圍開啓 | → 重量相等 |
| 04/13/2021 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
| 04/13/2021 | 9069.05% | Truist 證券 | → 32 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Instil Bio (TIL)?
Instil Bio（TIL）的目標價格是多少？
The latest price target for Instil Bio (NASDAQ: TIL) was reported by HC Wainwright & Co. on November 14, 2023. The analyst firm set a price target for $2.00 expecting TIL to rise to within 12 months (a possible 473.07% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月14日公佈了Instil Bio（納斯達克股票代碼：TIL）的最新目標股價。該分析公司將目標股價設定爲2.00美元，預計TIL將在12個月內上漲至2.00美元（可能上漲473.07％）。去年有6家分析公司公佈了評級。
What is the most recent analyst rating for Instil Bio (TIL)?
Instil Bio（TIL）的最新分析師評級是多少？
The latest analyst rating for Instil Bio (NASDAQ: TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.
Instil Bio（納斯達克股票代碼：TIL）的最新分析師評級由HC Wainwright & Co. 提供，Instil Bio重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Instil Bio (TIL)?
Instil Bio（TIL）的下一個分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Instil Bio的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Instil Bio的最後一次評級是在2023年11月14日提交的，因此您應該預計下一個評級將在2024年11月14日左右公佈。
Is the Analyst Rating Instil Bio (TIL) correct?
Instil Bio（TIL）的分析師評級是否正確？
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $0.00 to $2.00. The current price Instil Bio (TIL) is trading at is $0.35, which is within the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但最新的Instil Bio（TIL）評級得到了重申，目標股價爲0.00美元至2.00美元。Instil Bio（TIL）目前的交易價格爲0.35美元，在分析師的預測區間內。